Treatment of Children With Obstructive Sleep Apnea and Laryngomalacia: the Role of Laser Supraglottoplasty
Information source: Indiana University
Information obtained from ClinicalTrials.gov on November 03, 2008 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Sleep Apnea, Obstructive; Respiration Disorders
Intervention: supraglottoplasty with laser (Procedure); laser supraglottoplasty (Procedure)
Phase: N/A
Status: Recruiting
Sponsored by: Indiana University School of Medicine Official(s) and/or principal investigator(s): Bruce H. Matt, MD, MS, Principal Investigator, Affiliation: Indiana University School of Medicine
Overall contact: Bruce H Matt, MD, MS, Phone: 317-274-6670
Summary
This is a research study of the effect of treating laryngomalacia (floppiness of tissue on
top of the voice box that can possibly block breathing) found in association with obstructive
sleep apnea (blockage of breathing while sleeping).
The purpose of this study is to determine which is the best treatment for children with
obstructive sleep apnea and laryngomalacia: adenotonsillectomy alone or adenotonsillectomy
with laser supraglottoplasty (removal of tissue on top of the voice box to open the airway).
Clinical Details
Official title: Treatment of Children With Obstructive Sleep Apnea and Laryngomalacia: the Role of Laser Supraglottoplasty
Study design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Primary outcome: as measured by overnight polysomnogram:Changes in minimum oxygen saturation Changes in Respiratory Disturbance index Changes in peak end-tidal carbon dioxide(CO2) level Changes in mean end-tidal carbon dioxide(CO2) level
Secondary outcome: overall category of airway obstruction on polysomnogram (e.g. normal, mild, moderate, severe obstructive sleep apnea)
Detailed description:
If you agree to have your child be in the study, you will do the following things:
you are consenting to your child having the adenoid (tissue similar to lymph nodes, found in
the back of the throat) and tonsils removed (if not previously performed), direct
laryngoscopy (looking in the throat) and bronchoscopy (inspection of the lungs with a long
tube-like device down the throat), and randomization (½ will be treated further, ½ will be
observed) into treatment and no-treatment arms if your child is diagnosed with
laryngomalacia. After starting general anesthesia (putting patient to sleep for procedure),
the surgeon will perform direct laryngoscopy (look at the throat and voice box) and
bronchoscopy (look at the entrance to the lungs [trachea or windpipe]). If your child is
diagnosed with laryngomalacia (flopping of the tissue around the voice box, potentially
causing obstruction or blockage), 50% will undergo a further treatment (laser
supraglottoplasty, or removal of tissue at the entrance of the voice box) and 50% will be
observed. The decision to treat or not treat will be random, as is customary for prospective
research trials. All children (both treatment arms will receive a 3 week treatment of a
medicine (a proton pump inhibitor) to reduce the level of stomach acid and prevent potential
exposure of the larynx (voice-box) to stomach acid. If your child does not have
laryngomalacia, no further treatment on the larynx (voice-box) will be performed. Next,
adenotonsillectomy will be performed as is common for the Otolaryngologist performing the
procedure. Postoperatively, a sleep study will be performed (identical to the preoperative
study) ideally 3-6 months after surgery, (but up to one year after) to monitor your child's
progress. Additional laboratory tests or drawing of blood is not routine in this procedure,
but may be performed as dictated by your child's medical conditions.
Eligibility
Minimum age: 1 Year.
Maximum age: 18 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- 1 year old to 18 years of age, clinical signs or symptoms of obstructive sleep apnea
(snoring, witnessed apneas, daytime somnolence, restless sleeping, or cyanosis),
abnormal polysomnogram (mild, moderate, or severe OSA) including CO2 measures, failed
or refused trial of CPAP, or not recommended by their pulmonologist or primary care
doctor.
Exclusion Criteria:
- prior laser supraglottoplasty, prior adenoidectomy prior tonsillectomy, stridor with
cyanosis or apnea, severe respiratory distress, recurrent pneumonia (x3), Laryngeal
cyst, vocal cord (VC) Paralysis, airway vascular malformation, neoplasm, subglottic
hemangioma, paradoxical vocal cord (VC) motion, posterior glottic stenosis, glottic
webs, discoordinate pharyngolaryngomalacia, or refusal to participate.
Locations and Contacts
Bruce H Matt, MD, MS, Phone: 317-274-6670
Riley Childrens' Hospital, Indianapolis, Indiana 46202, United States; Recruiting Shelley Bizila, Phone: 317-274-8289, Email: resrisk@iupui.edu Bruce H Matt, MD, MS, Principal Investigator
Additional Information
Starting date: January 2002
Ending date: December 2018
Last updated: May 6, 2008
|